Clinical Trial Update: Clinical Tolerance to a Live Attenuated Vaccine Against Influenza (Flumist®) in a Population Allergic to Eggs

View source ↗

Summary

A completed clinical trial assessed tolerance of Flumist in individuals with egg allergy. The results suggest the vaccine is tolerated in this population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Egg Allergy

Drugs mentioned

• FluMist (live attenuated influenza vaccine)

Snippet

Sponsor: St. Justine's Hospital | Conditions: Egg Allergy | Status: COMPLETED